DNA nanorobots target HER2-positive breast cancer cells
from American Chemical Society via Lab Manager
According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal growth factor receptor 2. When displayed on the surface of cancer cells, this signaling protein helps them proliferate uncontrollably and is linked with a poor prognosis.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063